FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/07/2022
Voltar para busca
Dado oficial do USPTO
CELL TECHNA GENE THERAPY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
18/07/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
14/10/2020
Data de registro
11/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/01/2022
Última transação
11/01/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
LT
Examinador
LIEBL, ALEXANDRA
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "CELL TECHNA" in dark blue where the wording "CELL" is within four stylized curved bands. The top left and lower right curved bands are orange, the top right and lower left smaller bands are dark blue. Underneath the wording "TECHNA" is the stylized wording "gene therapy" in orange.
Titulares e representantes
Titulares
UAB "NORTHWAY TURTO VALDYMAS"
Representantes
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19; drugs for medical purposespharmaceutical preparations for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19
Classe 42
Scientific and technological servicesresearch and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; scientific laboratory services; technological consultation in the field of development of manufacturing processes for biotechnology products
Classe 44
Medical services; midwife services; alternative medicine services; in vitro fertilization services; chiropractic services; physiotherapy; occupational therapy services; human tissue bank services; hospital services; rental of medical equipment; medical advice for individuals with disabilities; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; opticians' services; plastic surgery; services of a psychologist; convalescent home services; preparation of prescriptions by pharmacists; rehabilitation of substance abuse patients; nursingmedical; health centre services; health counselling; medical screening; health care; telemedicine services
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/06/2022
FIMP
FINAL DISPOSITION PROCESSED
27/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/10/2021
PUBO
PUBLISHED FOR OPPOSITION
26/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
20/09/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/09/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
20/09/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/09/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/07/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
18/05/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
16/05/2021
RFNT
REFUSAL PROCESSED BY IB
13/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/03/2021
RFRR
REFUSAL PROCESSED BY MPU
22/03/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/03/2021
CNRT
NON-FINAL ACTION WRITTEN
17/03/2021
DOCK
ASSIGNED TO EXAMINER
15/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELL TECHNA GENE THERAPY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.